VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1650273
Sex: F
Age:
State: ND

Vax Date: 04/13/2021
Onset Date: 04/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Arm pain; Headache; Fever; Chills; Stomach upset; Fatigue; Body aches; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 13Apr2021 at 16:30 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. Medical history included diabetic, asthmatic, high blood pressure, depression, anxiety and COVID-19. Concomitant medications included metformin hydrochloride, sitagliptin phosphate monohydrate (JANUMET), ibuprofen (MANUFACTURER UNKNOWN), lisinopril (MANUFACTURER UNKNOWN), ethinylestradiol, norgestimate (SPRINTEC) and acetylsalicylic acid (ASPIRIN) all for an unknown indication from an unknown date and unknown if ongoing. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 12:15, the patient experienced arm pain, headache, fever, chills, stomach upset, fatigue and body aches. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events arm pain, headache, fever, chills, stomach upset, fatigue and body aches were recovered on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: JANUMET; IBUPROFEN; LISINOPRIL; SPRINTEC; ASPIRIN [ACETYLSALICYLIC ACID]

Current Illness:

ID: 1650274
Sex: F
Age:
State: UT

Vax Date: 03/31/2021
Onset Date: 04/03/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: experiencing recurring migraines.; experiencing recurring migraines and sensitivity to light.; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0150) via an unspecified route of administration in the left arm on 31Mar2021 at 13:30(at the age of 45-year-old) as a single dose for COVID-19 immunisation. Medical history were reported as none. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 11:30, the patient experienced recurring migraines and sensitivity to light. The patient did not receive any treatment for the reported events. The clinical outcome of the events recurring migraines and sensitivity to light were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650275
Sex: F
Age:
State: IN

Vax Date: 03/20/2021
Onset Date: 03/20/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Headache; literally cant sleep; Severe allergies nasal/throat; itching skin; loss of smell; severe allergies; nausea; puking; hot/cold body temp with low grade temp; Pain in hands and feet; Pain in hands and feet; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 20Mar2021 at 07:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation and also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 10Apr2021 at 07:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included lupus, type 2 diabetes mellitus, kidney disease, Postural Orthostatic Tachycardia Syndrome (POTS), Ehlers-Danlos Syndrome (EDS) and Interstitial Cystitis (IC). The patient had unspecified allergies. The patient received unspecified medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Mar2021, the patient experienced headache, literally could not sleep, had severe allergies of nasal/throat and itching skin, loss of smell, severe allergies, nausea and puking, hot/cold body temperature with low grade temperature and pain in hands and feet. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events headache, literally could not sleep, had severe allergies of nasal/throat and itching skin, loss of smell, severe allergies, nausea and puking, hot/cold body temperature with low grade temperature and pain in hands and feet were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650276
Sex: M
Age:
State:

Vax Date: 03/22/2021
Onset Date: 03/31/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Hives on legs and torso and they were multiplying; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 22Mar2021 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Medical history included diabetic on an unknown date and ongoing. Concomitant medications included dulaglutide (TRULICITY) for diabetic from an unknown date. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021, the patient hives on legs and torso and they were multiplying. Therapeutic measures were not taken as a result of these events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event hives on legs and torso and they were multiplying was not recovered at the time of this report. The patient later received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep7534) via an unspecified route of administration in the left arm on 13Apr2021 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: TRULICITY

Current Illness: Diabetic (On trulicity)

ID: 1650277
Sex: F
Age:
State: CO

Vax Date: 04/12/2021
Onset Date: 04/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210413; Test Name: Heart rate; Result Unstructured Data: Test Result:Rapid; Comments: 12:00

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Rapid heart rate; This is a spontaneous report from a non-contactable consumer, the patient. A 24-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW1053) via an unspecified route of administration in the left arm on 12Apr2021 at 17:30 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and COVID-19. The patient had no known allergies to medications, food, or other products. Prior to vaccination, the patient was diagnosed with COVID-19.The patient did not receive any concomitant medications The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 12:00, the patient experienced rapid heart rate. Since the vaccination, the patient had not been tested for COVID-19. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event rapid heart rate was unknown at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1650278
Sex: F
Age:
State: FL

Vax Date: 04/12/2021
Onset Date: 04/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Headache; Slight arm pain; Fatigue; Grogginess; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO161) via an unspecified route of administration in the left arm on 12Apr2021 at 12:30 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Other medical history was reported as none. The patient had no known allergies to medication, food or any other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included chorionic gonadotrophin (NOVAREL), arginine (L-ARGININE), fish oil (MANUFACTURER UNKNOWN), ubidecarenone; linum usitatissimum seed oil; conjugated linoleic acid (COQ10) and prenatal (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 12:30, the patient experienced slight arm pain, headache, grogginess and fatigue. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events slight arm pain, headache, grogginess and fatigue was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: NOVAREL; L-ARGININE [ARGININE]; FISH OIL; COQ10 [CONJUGATED LINOLEIC ACID;LINUM USITATISSIMUM SEED OIL;UBIDECARENONE]

Current Illness:

ID: 1650279
Sex: F
Age:
State: TX

Vax Date: 04/09/2021
Onset Date: 04/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Facial swelling for several days; Heart palpitations; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 09Apr2021 at 13:30 (at the age of 39-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 15:00, the patient experienced facial swelling for several days and heart palpitations. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events and included treatment with steroid prescription. The clinical outcome of the events facial swelling for several days and heart palpitations were resolving at the time of reporting. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1650280
Sex: M
Age:
State: NY

Vax Date: 04/12/2021
Onset Date: 04/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Tiredness; Pain in arm at injection site; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 12Apr2021 at 15:00 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Medical history included hypertension. Concomitant medications included ascorbic acid, cyanocobalamin, ergocalciferol, nicotinamide, pyridoxine hydrochloride, retinol, riboflavin, thiamine mononitrate (ONE-A-DAY) and amlodipine (MANUFACTURER UNKNOWN) from an unknown start date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021 at 21:00 the patient experienced pain in arm at vaccination site and tiredness. Since the vaccination, the patient had not been tested for COVID-19. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the event pain in arm at vaccination site was recovered on 13Apr2021 after the duration of 24 hours. The clinical outcome of the event tiredness was recovering at the time of reporting. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: ONE-A-DAY [ASCORBIC ACID;CYANOCOBALAMIN;ERGOCALCIFEROL;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL; AMLODIPINE

Current Illness:

ID: 1650281
Sex: F
Age:
State: NJ

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: joint aches; chills; intense tiredness; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on an unknown date in Mar2021 at 14:45 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included discoid lupus. The patient previously received penicillin on an unknown date for an unknown indication and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on an unknown date in Feb2021 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Concomitant medications included hydroxychloroquine (MANUFACTURER UNKNOWN), montelukast sodium (MONTELUKAST), multivitamin and allergy medications; all from an unknown date for an unknown indication an unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Mar2021, approximately 12 hours after receiving 2nd dose, the patient experienced joint aches, 18 hours after 2nd dose, the chills began as well an intense tiredness. These symptoms lasted until about 3pm the day after the 2nd dose (a full 24 hours) before these lessened. First the chills subsided, then the achy joints. The following day, all reactions had subsided completely. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The patient did not receive any treatment for the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events joint ache, chills and tiredness was recovered on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds: HYDROXYCHLOROQUINE; MONTELUKAST

Current Illness:

ID: 1650282
Sex: F
Age:
State: MN

Vax Date: 03/31/2021
Onset Date: 03/31/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Tired; Brain Fogg; Dizzy; Nausea within first 15 minutes.; This is a spontaneous report from a contactable consumer, the patient. A 70-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 31Mar2021 at 16:30 (at the age of 70-years-old), as a single dose for COVID-19 immunisation. Medical history included kidney disease and bipolar. Concomitant medications included temazepam (MANUFACTURER UNKNOWN), diazepam (MANUFACTURER UNKNOWN), quetiapine fumarate (SEROQUEL), cetirizine (MANUFACTURER UNKNOWN) and unspecified vitamin; all for unknown indication from unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 11Mar2021 at 16:30 (at the age of 70-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had no known allergies to medications, food or other products. On 31Mar2021, the patient experienced nausea within first 15 minutes of vaccination. On 01Apr2021 at 12:00, the patient experienced tired, brain fog and dizzy. The events persisted for more than 2 weeks. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of tired, brain fog and dizzy and included treatment with meclizine. The clinical outcome of the event nausea was recovered on 31Mar2021, subsided 2 to 3 hours later. The clinical outcome of the event tired, brain fog and dizzy was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: TEMAZEPAM; DIAZEPAM; SEROQUEL; CETIRIZINE

Current Illness:

ID: 1650283
Sex: M
Age:
State: MO

Vax Date:
Onset Date: 03/31/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210329; Test Name: Flu/COVID; Test Result: Negative ; Comments: Nasal Swab; Test Date: 20210329; Test Name: Strep Throat; Test Result: Negative

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Stye on right eye; Left ankle pain; Right foot bruising; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 11Mar2021 at 14:00(at the age of 24-years-old) as a single dose and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 08Apr2021 as a single dose for COVID-19 immunisation. Medical history included prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient had no known allergies. On 31Mar2021 at 09:00 the patient experienced, stye on right eye, left ankle pain and right foot bruising. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On 29Mar2021, the patient underwent nasal swab and the test result was negative and on 29Mar2021, the patient underwent COVID-19 virus test and test result was negative. The clinical outcome of the event stye on right eye, left ankle pain and right foot bruising was not recovered at the time of this report. No follow-up attempts are needed; information about lot number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1650284
Sex: F
Age:
State: NH

Vax Date: 04/12/2021
Onset Date: 04/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 12Apr2021 at 10:00(at the age of 36-year-old) as a single dose for COVID-19 immunisation. The patient did not have a medical history. The patient was not allergic to food, medication or other product. Concomitant medications included ferrous sulfate/folic acid/zinc (PRENATAL) and fish oil/rosmarinus officinalis/tocopherol (ULTIMATE OMEGA) both are started from an unknown date and unknown if ongoing for an unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021 at 14:00 the patient experienced diarrhoea. Therapeutic measures were not taken as a result of the event. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event diarrhoea was not recovered at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds: PRENATAL [FERROUS SULFATE;FOLIC ACID;ZINC]; ULTIMATE OMEGA

Current Illness:

ID: 1650285
Sex: M
Age:
State:

Vax Date: 03/31/2021
Onset Date: 03/31/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Then my right knee was hurting like i had tore something there to for 7 day; Starting an hour after the vaccine, For 5 days it felt like i had tore my rotator cuff in my left arm. After that went away,; This is a spontaneous report from a non-contactable consumer, the patient. A 30-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: er8732) via an unspecified route of administration in the left arm on 31Mar2021 at 14:00 (at the age of 30-years-old), as a single dose for COVID-19 immunisation. The medical history and concomitant medications of the patient were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 31Mar2021 at 15:00, starting an hour after the vaccine, the patient felt like he had a tore in his rotator cuff in his left arm for 5 days. After that it went away. On an unknown date in Apr2021, the patient experienced that his right knee was hurting like he had torn something there for 7 days. No therapeutic measures were taken for the reported events. The clinical outcome of the events rotator cuff tear in his left arm was recovered on an unknown date in Apr2021 and the clinical outcome of the event right knee hurting like he had torn something there was recovering at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1650286
Sex: F
Age:
State: SC

Vax Date: 04/07/2021
Onset Date: 04/09/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Severe rash covered 25% of body --head to mid-chest/back.; Face swelled; Lips swelled/tingled; Lips swelled/ tingled; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 07Apr2021 at 15:00 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history included latex allergy. Concomitant medications included cetirizine hydrochloride (ZYRTEC), vitamin d nos (VIT D), ascorbic acid (VIT C), sodium ascorbate, vaccinium macrocarpon, lactobacillus acidophilus, lactobacillus rhamnosus, bacillus coagulans, fructooligosaccharides (VH ESSENTIALS PROBIOTICS WITH PREBIOTICS & CRANBERRY) and withania somnifera root (ASHWAGANDHA ROOT) for unknown indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 00:00, the patient experienced severe rash covered 25% of body - head to mid chest/back, face swelled, lips swelled and tingled. No apparent stimulus for reaction, the patient last ate 6hrs before event and had only drank water since. Managed to get it under control after 2 days of regular Benadryl dosing. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with 2 days of regular diphenhydramine (BENADRYL). The clinical outcome of the events severe rash covered 25% of body - head to mid chest/back, face swelled, lips swelled and tingled was recovered on an unknown date in Apr2021. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: ZYRTEC [CETIRIZINE HYDROCHLORIDE]; VIT D [VITAMIN D NOS]; VIT C; VH ESSENTIALS PROBIOTICS WITH PREBIOTICS & CRANBERRY; ASHWAGANDHA ROOT

Current Illness:

ID: 1650287
Sex: F
Age:
State: CA

Vax Date: 04/12/2021
Onset Date: 04/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: sleep paralysis; Tiredness; sleepiness; soreness at injection site; This is a spontaneous report from a contactable healthcare professional. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 12Apr2021 at 09:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Other medical history was reported as not available. The patient had no known allergies to medications, food, or other products. Concomitant medications taken within two weeks of vaccination included fluconazole (MANUFACTURER UNKNOWN) from unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021 at 11:00, the patient experienced tiredness, sleepiness, sleep paralysis, soreness at injection site. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events tiredness, sleepiness, sleep paralysis, soreness at injection site was resolving at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: FLUCONAZOLE

Current Illness:

ID: 1650288
Sex: M
Age:
State: NY

Vax Date: 04/06/2021
Onset Date: 04/09/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Dry hive like patches that started on arm, back, chest and torso.; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN0153) via an unspecified route of administration in the arm left on 06Apr2021 at 15:00 (at the age of 25-year-old) as a single dose for COVID-19 immunisation. The patient's medical history included COVID-19 from an unknown date to unknown date. Concomitant medications included restylane filler (MANUFACTURER UNKNOWN) started on 04Feb2021 for unknown indication. The patient had no known allergies. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021, the patient experienced dry hive like patches on arm which extended to back, chest, and torso. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of this event. The clinical outcome of the event dry hive like patches on back, chest, and torso was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650289
Sex: M
Age:
State:

Vax Date: 04/12/2021
Onset Date: 04/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data: Test Date: 20210413; Test Name: body temperature; Result Unstructured Data: Test Result:99.2

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: fever (99.2); headache; stomach upset; body aches; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 12Apr2021 at 08:45 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. Medical history included obesity. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 22Mar2021 at 08:45 as a single dose for COVID-19 immunisation. On 13Apr2021 at 01:00, the patient underwent test for body temperature and the result was fever with 99.2. The patient had no known allergies. On 12Apr2021 at 20:00, the patient experienced body aches, headache and stomach upset. On 13Apr2021 at 01:00 the patient experienced fever. The patient did not receive any treatment for the event. The adverse event did not result in visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome for the events general body pain, headache and stomach upset were recovering and of the event fever was resolved. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650290
Sex: F
Age:
State: CO

Vax Date: 04/12/2021
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Numbness and tingling in leg; Numbness and tingling in leg; Throbbing pain in same leg.; This is a spontaneous report from a contactable consumer, the patient. A 30-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 12Apr2021 at 15:45 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history included latex allergy. Concomitant medications included lisdexamfetamine mesilate (VYVANSE), vortioxetine hydrobromide (TRINTELLIX) and montelukast sodium (SINGULAIR), all from unknown dates and for unknown indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021 at 18:30, the patient experienced numbness and tingling in leg and throbbing pain in same leg. The patient did not receive any treatment for the reported events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the event numbness, tingling and throbbing pain in leg was not resolved at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: VYVANSE; TRINTELLIX; SINGULAIR

Current Illness:

ID: 1650291
Sex: F
Age:
State: MN

Vax Date: 04/12/2021
Onset Date: 04/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Bumps appeared on lmy ips; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old, non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route on 12Apr2021 at 14:30 in the left arm (at the age of 49-years-old) as single dose for COVID-19 immunisation. The medical history of the patient included possible penicillin allergy. The patient did not receive other medication within 2 weeks of COVID-19 vaccine. The patient did not receive other vaccination within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Previously, the patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route on 25Mar2021 at 13:30 (at the age of 49-years-old) in the right arm as single dose for COVID-19 immunisation. Post the vaccination, the patient was not tested for COVID-19. On 12Apr2021, the patient was not certain what caused this but she had not experienced this before. Bumps appeared on her lips. She thought it was a cold sore at first but there was no itching tingling. One that had grown in the last couple of days on the lower lip and many smaller bumps on the upper lip not responding to Abreva, which was what she would usually use on a cold sore as soon as she felt the tingling. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included Abreva (MANUFACTURER UNKNOWN). The clinical outcome of the event bumps appeared on lips was not recovered at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1650292
Sex: F
Age:
State: TX

Vax Date: 04/14/2021
Onset Date: 04/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data: Test Name: COVID-19 virus test; Test Result: Positive ; Comments: Patient was diagnosed with COVID-19 prior to vaccination.

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: The next day I couldnt do anything.; Joint pain; Muscle aches/Every joint in my body was burning and aching; Unable to sleep; Chills; Fever; Headache; This is a spontaneous report from a contactable nurse, the patient. A 56-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via intramuscular route of administration in the left arm on 14Apr2021 (at the age of 56-year-old) at 17:00 as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had allergies to fluconazole. Prior to the vaccination, the patient was diagnosed with COVID-19 on an unknown date. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included estradiol (ESTROGEN), omeprazole (MANUFACTURER UNKNOWN), acetylsalicylic acid (ASPIRIN)-all for unknown indication. On 14Apr2021 at 21:00, the patient experienced joint pain, muscle aches started, unable to sleep, chills, fever and headache. The patient reported that she couldn't do anything on 15Apr2021 and unable to get relief. Therapeutic measures were taken as a result of event and included treatment with Tylenol and the patient reported as unrelieved by the Tylenol. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of joint pain, muscle aches, unable to sleep, chills, fever and headache were recovering. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: ESTROGEN; OMEPRAZOLE; ASPIRIN [ACETYLSALICYLIC ACID]

Current Illness:

ID: 1650293
Sex: F
Age:
State: NY

Vax Date: 04/04/2021
Onset Date: 04/05/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: "I seem to be having bad hot flashes at night. she is in menopause and since the first COVID shot my hot flashes seem to have gotten 3 times worse at night".; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8730) via an unspecified route of administration in the right arm on 04Apr2021 at 15:15 (at the age of 55-years-old), as a single dose for COVID-19 immunisation. Medical history included irritable bowel and lactose intolerant. The patient had known allergies to medications, food or other products. Concomitant medications included vit d (MANUFACTURER UNKNOWN) of 1000 mg 1 pill pm and calcium carbonate, colecalciferol (CALTRATE) of 600 mg 1pill am, all from an unknown date for unknown indication. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 05Apr2021, the patient reported that she seemed to be having bad hot flashes at night, was in menopause and since the first COVID shot her hot flashes seemed to have gotten 3 times worse at night. The events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the event "she seem to be having bad hot flashes at night. she is in menopause and since the first COVID shot her hot flashes seem to have gotten 3 times worse at night" was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: VIT D [VITAMIN D NOS]; CALTRATE [CALCIUM CARBONATE; COLECALCIFEROL]

Current Illness:

ID: 1650294
Sex: M
Age:
State: MD

Vax Date: 04/03/2021
Onset Date: 04/04/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Pain in left arm (injection site); Pain in left arm (injection site); Mild headache that lingered most of the day (16 hours or so); Mild headache that lingered most of the day (16 hours or so) along with tiredness; Lack of energy; This is a spontaneous report from a contactable consumer. A 27-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8732) via an unspecified route of administration in the arm left on 03Apr2021 at 14:30 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not receive any other medications within two weeks of vaccination. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6208) via an unspecified route of administration the left arm on 13Mar2021 at 17:00 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021, the patient woke up on the morning with pain in left arm (injection site), mild headache that lingered most of the day (16 hours or so) along with tiredness and lack of energy. The symptoms were gone by the next day. Therapeutic measures were not taken as a result of the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events pain in left arm (injection site), mild headache, tiredness and lack of energy were recovered on the 05Apr2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1650295
Sex: F
Age:
State: TX

Vax Date: 04/13/2021
Onset Date: 04/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Chin, lips and tongue began in tingle; Slight bitter to bad taste formed in the back of throat; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 13Apr2021 at 13:00 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included sulfonamide allergy. Concomitant medications included fluticasone propionate (FLONASE), zinc (MANUFACTURER UNKNOWN), magnesium (MANUFACTURER UNKNOWN), vitamin d nos (VITAMIN D), pantothenic acid (MANUFACTURER UNKNOWN), antihistamine (MANUFACTURER UNKNOWN), yinviv ease tonic (MANAFACTURER UNKNOWN) all from an unknown date for an unspecified indication. The patient previously took naproxen (MANAFACTURER UNKNOWN) from an unknown date for an unspecified indication and experienced drug allergy. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 13:30, the patient experienced chin and lips and tongue began in tingle and a slight bitter and bad taste formed in the back of throat. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events chin and lips and tongue began in tingle and a slight bitter and bad taste formed in the back of throat was recovering. No follow-up attempts are needed. No further information is expected.

Other Meds: FLONASE [FLUTICASONE PROPIONATE]; ZINC; MAGNESIUM; VITAMIN D [VITAMIN D NOS]; PANTOTHENIC ACID

Current Illness: Sulfonamide allergy

ID: 1650296
Sex: F
Age:
State: NJ

Vax Date: 04/11/2021
Onset Date: 04/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Period started one week early; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 11Apr2021 at 13:30 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. The patients' medical history was reported as none. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant drugs include ethinylestradiol; norgestimate (TRI-LO SPRINTEC) for birth control from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 11Apr2021 at 14:30, the patient experienced her period which started one week early, an hour after she received her shot. The patient reported that her cycle was always the same, so it was strange for it to be irregular. The only thing different about routine was getting the first Pfizer shot. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event period started one week early was unknown at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: TRI-LO-SPRINTEC

Current Illness:

ID: 1650297
Sex: M
Age:
State: OR

Vax Date: 04/12/2021
Onset Date: 04/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: It kind of knocked 'me' out/fatigue; This is a spontaneous report from a contactable consumer reporting for a patient. An adult male patient of unknown age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 12Apr2021, as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. It was unknown if the patient received any other vaccines within four weeks prior to the vaccination. On 12Apr2021, in an email to the reporter, the patient (vendor) mentioned that after getting second dose of vaccine it kind of knocked him out. The reporter took this to mean fatigue since the patient did not elaborate. The clinical outcome of the event It kind of knocked 'me' out/fatigue was unknown at the time of the report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1650298
Sex: F
Age:
State: KS

Vax Date: 04/13/2021
Onset Date: 04/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: I developed a red, swollen lump at theinjection site; swollen lump at the injection site; hot to touch; I developed a red, swollen lump at the injection site; Itchy; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 13Apr2021 at 11:30 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient had no known allergies. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021, the patient experienced a red, swollen lump at the injection site the day after receiving the vaccine. The swollen area was about 2 inches and was circular. The skin of the swollen area was very red and hot to touch. On an unknown date in Apr2021, the patient experienced the bump became itchy. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events developed a red, swollen lump at the injection site, the skin of the swollen area was very red and hot to touch, bump became itchy was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650299
Sex: F
Age:
State: KS

Vax Date: 04/09/2021
Onset Date: 04/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Series of migraine flares; Hot flashes combined with ear; Sinus pain on day 4, 5, 6; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the arm left on 09Apr2021 at 13:30 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to penicillin. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included gliclazide (CLARITIN), vitamins nos (MULTIVITAMIN) and mefenamic acid (ADVIL), all from an unknown date for an unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 09:00, the patient experienced series of migraine flares, hot flashes and sinus pain on day 4, 5, 6. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events migraine, hot flashes and sinus pain was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: CLARITIN [GLICLAZIDE]; MULTIVITAMIN [VITAMINS NOS]; ADVIL [MEFENAMIC ACID]

Current Illness:

ID: 1650300
Sex: M
Age:
State: LA

Vax Date: 04/12/2021
Onset Date: 04/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Light headache; Light Body pain; Light fever; This is a spontaneous report from a non-contactable consumer, the patient. A 29-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN), via an unspecified route of administration in the right arm on 12Apr2021 at 09:45 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 22Mar2021 at 09:45 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. On 13Apr2021 at 01:00, the patient experienced light headache, light body pain and light fever. No therapeutic measures were taken as the result of adverse events. The adverse event did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not tested for COVID-19. The clinical outcomes of the events, light headache, light body pain and light fever was recovering at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1650301
Sex: F
Age:
State: NY

Vax Date: 04/02/2021
Onset Date: 04/05/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: pregnant; Large pain full rash developed 4 daysafter injection and has continued tospread now 10 days later; This is a spontaneous report from a contactable consumer (patient). A 36-years-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: Unknown), via an unspecified route of administration on 02Apr2021 at 16:00 (at the age of 36-years) as dose 1, single in the left arm for covid-19 immunisation. The patient medical history included irritable bowel syndrome with diarrhoea (IBS-D), cholecystectomy kidney stones and COVID-19. The patient concomitant medications included prenatal vitamins (MANUFACTURER UNKNOWN). The patient's last menstrual period was 25Aug2020 and due date was 13Jun2021. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 05Apr2021, 4 days after vaccination, the patient developed large painful rash and had continued to spread 10 days later. The patient received the vaccine during 29 weeks of pregnancy and hence maternal exposure during pregnancy, third trimester. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the event. The outcome of the event large painful rash was not resolved and other event was unknown. The lot number for BNT162b2 was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1650302
Sex: F
Age:
State: IL

Vax Date: 04/12/2021
Onset Date: 04/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Sore armpit; Felt unwell; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 12Apr2021 at 12:45 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On an unknown date in Apr2021, the patient experienced sore armpit and felt unwell. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken for the reported events, The clinical outcome of the event sore armpit and felt unwell were recovered on an unknown date in Apr2021, at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1650303
Sex: M
Age:
State: MO

Vax Date: 04/15/2021
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Rash and hives on torso; Rash and hives on torso; This is a spontaneous report from a contactable consumer, the patient. A 17-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the right arm on 15Apr2021 at 10:45 (at the age of 17-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021 at 21:00, the patient experienced rash and hives on torso. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events rash and hives on torso were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650304
Sex: F
Age:
State: WI

Vax Date: 03/26/2021
Onset Date: 03/26/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: very dizzy on day 3 and 4 of vaccine; Within 90 mins of the vaccine mymouth started to tingle; tongue started to swell; My lymph nodes under mychin were also a little swollen andwent down after a day; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 26Mar2021 at 13:30 (at the age of 57-year-old), as a single dose for COVID-19 immunisation. Medical history included type 2 diabetes mellitus. The patient did not receive any medication within two weeks of vaccination. The patient previously received erythromycin (MANUFACTURER UNKNOWN) on unknown date for unspecified indications and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 26Mar2021, within 90 mins of the vaccine, the patient's mouth started to tingle, tongue started to swell, though it did not cut off breathing it was noticeable for 4 hours. On 26Mar2021, the patient's lymph nodes under chin were also a little swollen and went down after a day. On 28Ma2021, day 3 and 4 after vaccine, the patient was very very dizzy. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events mouth started to tingle and tongue started to swell was recovered on 26Mar2021, and of the event little swollen lymph nodes under chin was recovered on 27Mar2021, and of the event very very dizzy was recovering, at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1650305
Sex: F
Age:
State: CO

Vax Date: 04/08/2021
Onset Date: 04/08/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Headache lasting more than 7 days; Itching entire body; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 08Apr2021 at 14:45 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, allergies, anxiety, hypothyroidism and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included cetirizine hydrochloride (ZYRTEC), sertraline hydrochloride (ZOLOFT), montelukast sodium (SINGULAIR), vitamin b complex (MANUFACTURER UNKNOWN) and magnesium (MANUFACTURER UNKNOWN); all from unknown dates for unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took Hepatitis b vaccine and experienced allergy to the vaccine. On 08Apr2021 at 15:15, the patient experienced headache lasting more than 7 days and itching entire body. The event resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event headache was recovering while that of the itching entire body was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ZYRTEC [CETIRIZINE HYDROCHLORIDE]; ZOLOFT; SINGULAIR; VIT B COMPLEX; MAGNESIUM

Current Illness:

ID: 1650306
Sex: F
Age:
State: IL

Vax Date: 04/05/2021
Onset Date: 04/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Vaccine given in same arm and same location arm feels weak.; Arm tingling; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Apr2021 at 14:45 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccination. The patient did not receive any other medications within two weeks. On 13Apr2021 at 06:00, 8 days after vaccination, the patient had experienced weak arm and tingling as if it was sleeping in the same location in same arm of vaccine given. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events weak arm and tingling was not resolved at the time of report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1650307
Sex: F
Age:
State: WA

Vax Date: 04/13/2021
Onset Date: 04/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: severe muscle pain surrounding injection site; inflammation; fever; minor hives; nausea; fatigue; Severe muscle pain surrounding injection site; This is a spontaneous report from a contactable consumer, the patient. A 24-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 13Apr2021 at 16:45 (at the age of 24-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma, stomach upset and major depressive disorder. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received amoxicillin (MANUFACTURER UNKNOWN) and chlorhexidine towelette (MANUFACTURER UNKNOWN) on an unspecified date for an unknown indication and experienced drug allergy. The patient had no known allergies to medications, food or other products. Concomitant medications included drospirenone (MANUFACTURER UNKNOWN) from 13Apr2021 at 16:45 and ethinylestradiol (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 the patient experienced severe muscle pain surrounding injection site, inflammation, mild fever, minor hives surrounding injection site, nausea, and fatigue all within 2 days of receiving the vaccine. Hives developed 2 days later, muscle pain receding. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the adverse events. The clinical outcome of the event severe muscle pain surrounding injection site, inflammation, fever, minor hives, nausea and fatigue was resolving at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: DROSPIRENONE; ETHINYLESTRADIOL

Current Illness:

ID: 1650308
Sex: F
Age:
State: NJ

Vax Date: 04/12/2021
Onset Date: 04/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data: Test Date: 20210413; Test Name: Body temperature; Result Unstructured Data: Test Result:101.2; Comments: 100.8-101.2 fever; Test Date: 20210413; Test Name: Body temperature; Result Unstructured Data: Test Result:100.8; Comments: 100.8-101.2 fever

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Left lymph node under armpit has swelled significantly; 100.8-101.2 fever; Strong headache; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 12Apr2021 at 12:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included psoriasis and psoriatic arthritis. The patient was allergic to penicillin (PCN). Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) and diphenhydramine, paracetamol, phenylpropanolamine hydrochloride (BENADRYL), both taken for unspecified indications from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 22Mar2021 at 12:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID -19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 08:00, 20 plus hours after the vaccination, the patient had fever of 100.8 to 101.2, strong headache and on 13Apr2021 at 18:00, 30 hours after the vaccination, the patient experienced that the lymph node under armpit had swelled significantly and the patient was unable to put the arm down. The patient did not seek treatment and wanted to reevaluate next morning. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events fever, strong headache and left lymph node under armpit had swelled were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: IBUPROFEN; BENADRYL

Current Illness:

ID: 1650309
Sex: M
Age:
State: CA

Vax Date: 03/11/2021
Onset Date: 03/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: This is a spontaneous report from a contactable consumer (patient). A 39-year-old male patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# unknown), at the age of 39, via unspecified route of administration, left arm, on Mar 11, 2021, at 10:00; and received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# unknown), at the age of 39, via unspecified route of administration, left arm on Apr 1, 2021, at 13:30, single dose, for COVID-19 immunisation. Medical history reported as not available. The patient did not have allergies to medications, food, or other products. The patient did not receive any other medications within two weeks prior to the vaccination. Prior to the vaccination, patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On Mar 12, 2021, at 18:00, patient experienced tinnitus after first shot, which was significantly stronger tinnitus after second shot and there was no prior known tinnitus. Since the vaccination, patient has not tested for COVID-19. The event resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether the patient received treatment for the event. The outcome of the tinnitus after first shot, which was significantly stronger tinnitus after second shot: not recovered at the time of this report. No follow-up attempts needed. Information about lot/batch number cannot be obtained. No further information expected.

Other Meds:

Current Illness:

ID: 1650310
Sex: F
Age:
State: NY

Vax Date: 03/16/2021
Onset Date: 03/17/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Rash started at injection site and went down to a scar which was due to a tuberculosis vaccine administered to me as an infant; little redness only at scar one week later; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the right arm on 16Mar2021 at 15:45 (at the age of 68-years-old), as a single dose for COVID-19 immunisation. Medical history included breast cancer on 2006, lumpectomy, radiation treatments, allergies to crafting and allergies to sulfa products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included atorvastatin 10 mg (MANUFACTURER UNKNOWN), metagenics bone builder forte (MANUFACTURER UNKNOWN) both for an unknown indication from an unknown date. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On an unknown date, the patient previously received tuberculosis vaccine which was administered as an infant in Italy. On 17Mar2021 at 12:00, the patient experienced rash which developed within 24 hours which started at injection site and went down to a scar which was due to a tuberculosis vaccine administered to her as an infant in Italy where she was born. The rash got better each day but at the time of report the patient had little redness only at scar one week later. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. No therapeutic measures were taken for the reported events. The clinical outcome of the event rash started at injection site and redness was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ATORVASTATIN

Current Illness:

ID: 1650311
Sex: M
Age:
State:

Vax Date:
Onset Date: 04/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Dizziness; Weakness; Fever; Chills; This is a spontaneous report from a non-contactable consumer, the patient. A 32-year-old male patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration on an unknown date (at the age of 32-year-old) as a single dose for COVID-19 immunisation. Medical history included heart failure. Concomitant medications were not reported. The patient had known allergies to pecan, cats and cefzil. Prior to vaccination, the patient was not diagnosed with COVID-19. On 13Apr2021 at 02:00, the patient experienced dizziness, weakness, fever and chills. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events- dizziness, weakness, fever and chills was recovering at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1650312
Sex: F
Age:
State: MA

Vax Date: 04/01/2021
Onset Date: 04/05/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Very heavy period days after vaccine; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 01Apr2021 at 15:15 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and allergy to a couple antibiotics. The patient did not receive any other medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 05Apr2021, the patient experienced very heavy period days after vaccine. The patient did not receive any treatment for the event. The clinical outcome of the event very heavy period days after vaccine was unknown at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1650313
Sex: F
Age:
State: CA

Vax Date: 03/16/2021
Onset Date: 03/17/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Blurry vision in left eye for past 4 weeks. started day after second dose.; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration on 16Mar2021 at 20:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to medications, food, or other products. Concomitant medications included bupropion hydrochloride (WELLBUTRIN), valaciclovir hydrochloride (VALTREX), vitamin b (MANUFACTURER UNKNOWN), vitamin d (MANUFACTURER UNKNOWN) all from unknown date for an unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 17Mar2021 at 14:00,day after second dose, the patient experienced blurry vision in left eye for past 4 weeks. The adverse event resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the reported event. The clinical outcome of blurry vision in left eye was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: WELLBUTRIN; VALTREX; VITAMIN B [VITAMIN B NOS]; VIT D [VITAMIN D NOS]

Current Illness:

ID: 1650314
Sex: F
Age:
State: OR

Vax Date: 04/13/2021
Onset Date: 04/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data: Test Date: 20210414; Test Name: Body temperature; Result Unstructured Data: Test Result:101 Units:[degF]; Comments: Body temperature 101 F

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Fever over 101 F; Chills; Nausea; Muscle ache; Fatigue; Sore throat; Headache; Neck pain; This is a spontaneous report from a contactable healthcare professional. A 22-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 13Apr2021 at 19:15 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included fluoxetine hydrochloride (PROZAC), vitamin B12 (MANUFACTUREER UNKNOWN) and colecalciferol (vitamin D3) (MANUFACTUREER UNKNOWN) from unknown dates, for unknown indications and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 23Mar2021 at 19:00 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 14Apr2021 at 03:30, the patient experienced fever over 101 (Fahrenheit), chills, nausea, muscle ache, fatigue, sore throat, headache and neck pain. The patient underwent lab tests and procedures, which included Body temperature on 14Apr2021 at 03:30 and resulted 101 (Fahrenheit). Therapeutic measures were taken as a result of the events which included treatment with acupuncture. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events fever over 101 (Fahrenheit), chills, nausea, muscle ache, fatigue, sore throat, headache and neck pain was recovering at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: PROZAC; VITAMIN B12 [VITAMIN B12 NOS]; VITAMIN D3

Current Illness:

ID: 1650315
Sex: M
Age:
State:

Vax Date: 03/20/2021
Onset Date: 04/04/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Intense chills,; fever; nausea; headache; fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 33-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL8734) via an unspecified route of administration on 20Mar2021(at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient had not been diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 04Apr2021 at 00:00 the patient experienced Intense chills, fever, nausea, headache, fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events Intense chills, fever, nausea, headache, fatigue were recovered with sequelae on an unknown date in Apr2021. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration on 10Apr2021(at the age of 33-year-old) as a single dose for COVID-19 immunisation. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1650316
Sex: F
Age:
State: MO

Vax Date: 03/19/2021
Onset Date: 03/19/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210324; Test Name: Body temperature; Result Unstructured Data: Test Result:100.2; Test Date: 20210323; Test Name: Body temperature; Result Unstructured Data: Test Result:100

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Feces looked kind of slimy (like gelatin on a canned ham); got up 5-6 times to pee (felt like I was going to bust) but had trouble starting flow; Belly ache in abdomen below navel pretty severe; Gassy; Got up 5-6 times to pee (felt like was going to bust); Head felt stuffy; Like ear aches starting; Slight headache; Fever; Extreme dizziness; Like vertigo had come back; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the right arm on 19Mar2021 at 09:00 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history included heart attack (stent) in May2020 patient reported to be on blood thinners for the same, cyst of kidney, kidney stone, surgery, back pain, shoulder pain and penicillin allergy. Concomitant medications included clopidogrel (MANUFACTURER UNKNOWN), metoprolol (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN), acetylsalicylic acid (ASPIRIN) all from an unknown date for an unspecified indication, and pneumococcal vaccine (MANUFACTURER UNKNOWN) on 19Mar2021 at 09:00 for unspecified indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the left arm on 23Feb2021 at 11:00 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient received other vaccines within four weeks prior to the vaccination. On 19Mar2021 at 16:00, the patient experienced slight headache, fever and extreme dizziness like vertigo had come back. On 23Mar2021, the patient experienced fever 100.0 she took one acetaminophen and it subsided; belly ache in abdomen below navel pretty severe, gassy, got up 5-6 times to pee felt like she was going to bust but had trouble starting flow, belly hurt just trying, head felt stuffy and like ear aches starting. On 24Mar2021 at 16:00, the patient experienced belly was tender but nothing like the day before, fever of 100.2 came back and feces looked kind of slimy (like gelatin on a canned ham), she took another acetaminophen. Patient stated that she texted her PCP what she felt all day, napped, drank a lot of water, appetite was normal. She had eaten popcorn on Monday. She stated to take extra fiber con to clean herself out, her PCP texted back on 25Mar2021 asking how she was. On 23Mar2021, the patient underwent body temperature and the result was 100 (UNSPECIFIED UNITS). On 24Mar2021, the patient underwent body temperature and the result was 100.2 (UNSPECIFIED UNITS). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events fever, feces looked kind of slimy and included treatment with acetaminophen. The clinical outcome of events slight headache, fever and extreme dizziness like vertigo, belly ache in abdomen, gassy, got up 5-6 times to pee felt like was going to bust but had trouble starting flow, belly hurt just trying, head felt stuffy and like ear aches starting, feces looked kind of slimy (like gelatin on a canned ham) was recovered on an unspecified date in Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds: CLOPIDOGREL; METOPROLOL; ATORVASTATIN; ASPIRIN [ACETYLSALICYLIC ACID]

Current Illness: Penicillin allergy

ID: 1650317
Sex: F
Age:
State: ME

Vax Date: 04/13/2021
Onset Date: 04/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Nausea; tiredness; leg cramp; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the arm left on 13Apr2021 at 12:00 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. The patient's medical history included fibromyalgia, tachycardia, dysrhythmias. The patient's allergies included sulfonamide allergy, penicillin allergy, pollen allergy, amoxicillin allergy, dairy allergy, grass allergy, trees allergy and mold allergy. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 16:30 the patient experienced nausea and tiredness and leg cramp. The patient had the worst leg cramp from the top of the leg right up into the groin, they continued all the way down to my ankle. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. No therapeutic measures were taken as a result of the events. The patient did not receive any treatment for the adverse events. The clinical outcomes of the events nausea and tiredness and leg cramp were recovering at the time of reporting. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1650318
Sex: M
Age:
State: CA

Vax Date: 04/14/2021
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Muscle pain; Tiredness; Pain in my left arm where vaccinated; This is a spontaneous report from a contactable consumer, the patient. A 18-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 14Apr2021 at 14:45 (at the age of 18-year-old) as a single dose for COVID-19 immunisation. The patient has allergy to pollen, mould, avocado, nuts and few others food products. Concomitant medications include cetirizine hydrochloride (ZYRTEC) for unspecified indication from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021 the patient experienced muscle pain, tiredness and pain in my left arm where vaccinated. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events muscle pain, tiredness and pain in my left arm was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ZYRTEC [CETIRIZINE HYDROCHLORIDE]

Current Illness:

ID: 1650319
Sex: F
Age:
State: IA

Vax Date: 04/14/2021
Onset Date: 04/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Headache; itchy; Achy joints; confusion; Tiredness; nauseous; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 14Apr2021 at 12:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included mitral valve prolapse, set episodes and anxiety. The patient was allergic to shellfish and Intravenous Pyelogram (IVP) contrast dye. Concomitant medications included bupropion XL (MANUFACTURER UNKNOWN), taken for an unspecified indication from an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 31Mar2021 at 12:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021, the patient experienced headache, itchy, achy joints, confusion, tiredness and felt nauseous. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events headache, itchy, achy joints, confusion, tiredness and felt nauseous were not resolved at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: BUPROPION

Current Illness:

ID: 1650320
Sex: F
Age:
State: NY

Vax Date: 04/09/2021
Onset Date: 04/09/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Tongue swelling / numbing; Tongue swelling / numbing; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 09Apr2021 at 08:45 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included endometriosis. The patient was allergic to ragweed and mugwort. Concomitant medications included levonorgestrel (MIRENA) Intrauterine Device (IUD) and multivitamin (PURE SYNERGY), both taken for unspecified indications from unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 09:00, about 15 minutes after the vaccine, the patient experienced tongue swelling/numbing. The event did not result in doctor or other healthcare professional office/clinic visit/ emergency visit. Therapeutic measures were taken as a result of the event and included treatment with liquid Benadryl. The clinical outcome of the event tongue swelling/numbing was resolved on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: MIRENA

Current Illness:

ID: 1650321
Sex: F
Age:
State:

Vax Date: 04/05/2021
Onset Date: 04/07/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Lump above from collarbone and swollen; Lump above from collarbone and swollen; This is a spontaneous report from a non-contactable consumer, the patient. A 32-year-old female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 05Apr2021 at 16:30 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 07Apr2021, two days after vaccination, the patient got a lump above from her collarbone and swollen. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether any therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events lump above from collarbone and swollen was not resolved at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1650322
Sex: F
Age:
State: WV

Vax Date: 03/18/2021
Onset Date: 03/21/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210326; Test Name: Nasal Swab test; Test Result: Negative

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Rapid heart rate; Dizziness; Extreme thirst; Chills; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 18Mar2021 at 00:00 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. Medical history included shellfish allergy, sulfa allergy and latex allergy. The patient did not receive any medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Mar2021 at 00:00, the patient experienced rapid heart rate, dizziness, extreme thirst and chills. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were taken as a result of events which included treatment with fluids and testing. On 26Mar2021, the patient underwent nasal swab test and the result was negative. The clinical outcome of the events rapid heart rate, dizziness, extreme thirst and chills was resolved with sequelae. The patient also received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 08Apr2021 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am